Spero Therapeutics, Inc. ($SPRO)
Filing Information
| Accession Number | 0001193125-26-043336 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
87,917
Total Value
$207,484.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Common Stock | โ | Feb 6, 2026 | Sale | 37,101 | $2.36 | $87,558.36 | 1,062,907 | Direct | โ | View Details | |
Chief Executive Officer, Chief Financial Officer and Chief Business Officer | Common Stock | โ | Feb 6, 2026 | Sale | 50,816 | $2.36 | $119,925.76 | 1,012,091 | Direct | โ | View Details |